precision

Oncodesign Precision Medicine (OPM) Announces IPO by Direct Listing on Euronext Access + Paris

Oncodesign Precision Medicine (OPM) Announces IPO by Direct Listing on Euronext Access + Paris

DIJON, France–(BUSINESS WIRE)–Regulatory news: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: MLOPM) (Paris:MLOPM), biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers, announces that it will be listed on Euronext Access + Paris by direct listing on October 5, 2022. Oncodesign Precision Medicine’s mission is the discovery of effective treatments …

Oncodesign Precision Medicine (OPM) Announces IPO by Direct Listing on Euronext Access + Paris Read More »

Euronext Paris authorizes the listing of Oncodesign Precision Medicine (OPM) shares on Euronext Access+ as part of the allocation of OPM shares to Oncodesign shareholders

Euronext Paris authorizes the listing of Oncodesign Precision Medicine (OPM) shares on Euronext Access+ as part of the allocation of OPM shares to Oncodesign shareholders

DIJON, France–(BUSINESS WIRE)–Regulatory news: Oncodesign Precision Medicine (OPM), subsidiary of Oncodesign (ALONC – FR0011766229) (Paris: ALONC), and Oncodesign announce that Euronext Paris SA has authorized on September 26, 2022 the admission to listing on the Euronext Access + market in Paris of the ordinary shares of OPM, within the framework of the direct listing procedure …

Euronext Paris authorizes the listing of Oncodesign Precision Medicine (OPM) shares on Euronext Access+ as part of the allocation of OPM shares to Oncodesign shareholders Read More »

“Rewriting the manual” for precision medicine

“Rewriting the manual” for precision medicine

Precision medicine puts the patient at the center of healthcare, using a variety of tools to develop tailored and targeted therapies and diagnostics. Promising to “revolutionize” the landscape of modern medicine, precision medicine requires in-depth knowledge of the molecular underpinnings of healthy and diseased states. Advances in molecular biology techniques and bioinformatics platforms help provide …

“Rewriting the manual” for precision medicine Read More »